At our Reading facility, we offer cGMP manufacturing to support Phase 1 and Phase 2 clinical trials in reactors up to 50 L, operating at temperatures from -90 °C to 200 °C. Late phase and large scale production is available at our facility in New Zealand. cGMP manufacture is supported by an analytical capability that includes method development and validation as well as forced degradation and stability studies, specification development and full QC testing of all incoming raw materials and intermediates. Our analytical facilities are equipped with qualified instrumentation which allows us to support all phases of our customer's projects.

Dextra Website

Together, NZP and Dextra offer a complete solution from route design and process development to full scale commercial cGMP manufacture.